Toshifumi Takeuchi

Toshifumi Takeuchi


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Life Sciences
Verified
Journal Article
Closed access
YMYoshiyuki Mizushina
Yoshiyuki Mizushina
TAToshihiro Akihisa
Toshihiro Akihisa
MUMotohiko Ukiya
Motohiko Ukiya
YHYusuke Hamasaki
Yusuke Hamasaki
CMChikako Murakami-Nakai
Chikako Murakami-Nakai
HYHiromi Yoshida
Hiromi Yoshida

20 January 2012 in Journal of Natural Products
Verified
Journal Article
Closed access
YMYusuke Myobatake
Yusuke Myobatake
TTToshifumi Takeuchi
Toshifumi Takeuchi
KKKouji Kuramochi
Kouji Kuramochi
IKIsoko Kuriyama
Isoko Kuriyama
TITomomi Ishido
Tomomi Ishido
YMYoshiyuki Mizushina
Yoshiyuki Mizushina

26 January 2017 in Organic Letters
Verified
Journal Article
Closed access
ZLZijian Liu
Zijian Liu
TTToshifumi Takeuchi
Toshifumi Takeuchi
RPRoman Pluta
Roman Pluta
FAFernando Arteaga Arteaga
Fernando Arteaga Arteaga
NKNaoya Kumagai
Naoya Kumagai
MSMasakatsu Shibasaki
Masakatsu Shibasaki

1 March 2009 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
TKTakuma Kimura
Takuma Kimura
TTToshifumi Takeuchi
Toshifumi Takeuchi
YKYuko Kumamoto-Yonezawa
Yuko Kumamoto-Yonezawa
EOEiji Ohashi
Eiji Ohashi
HOHaruo Ohmori
Haruo Ohmori
YMYoshiyuki Mizushina
Yoshiyuki Mizushina

20 January 2006 in Genes to Cells
Verified
Journal Article
Open access
PDF file
TTToshifumi Takeuchi
Toshifumi Takeuchi
TITomomi Ishidoh
Tomomi Ishidoh
HIHiroshi Iijima
Hiroshi Iijima
IKIsoko Kuriyama
Isoko Kuriyama
NSNoriko Shimazaki
Noriko Shimazaki
YMYoshiyuki Mizushina
Yoshiyuki Mizushina
We previously reported that phenolic compounds, petasiphenol and curcumin (diferuloylmethane), were a selective inhibitor of DNA polymerase λ (pol λ) in vitro. The purpose of this study was to investigate the molecular structural relationship of curcumin and 13 chemically synthesized derivatives of curcumin. The inhibitory effect on pol λ (full‐length, i.e. intact pol λ including the BRCA1 C‐ terminal [BRCT] domain) by some derivatives was stronger than that by curcumin, and monoacetylcurcumin (compound 13) was the strongest pol λ inhibitor of all the compounds tested, achieving 50% inhibition at a concentration of 3.9 µm. The compound did not influence the activities of replicative pols such as α, δ, and ɛ. It had no effect on pol β activity either, although the three‐dimensional structure of pol β is thought to be highly similar to that of pol λ. Compound 13 did not inhibit the activity of the C‐terminal catalytic domain of pol λ including the pol β‐like core, in which the BRCT motif was deleted from its N‐terminal region. MALDI‐TOF MS analysis demonstrated that compound 13 bound selectively to the N‐terminal domain of pol λ, but did not bind to the C‐terminal region. Based on these results, the pol λ‐inhibitory mechanism of compound 13 is discussed.

1 May 2007 in Biochimie
Verified
Journal Article
Closed access
YMYoshiyuki Mizushina
Yoshiyuki Mizushina
IDIssei Dairaku
Issei Dairaku
NYNoriyuki Yanaka
Noriyuki Yanaka
TTToshifumi Takeuchi
Toshifumi Takeuchi
CIChisato Ishimaru
Chisato Ishimaru
NKNorihisa Kato
Norihisa Kato